-
MK-2206 Dihydrochloride in HCC Angiogenesis
2026-09-22
Explore how MK-2206 dihydrochloride can help dissect extracellular-vesicle-driven PI3K/Akt signaling in hepatocellular carcinoma angiogenesis. This mechanistic guide connects Akt inhibition with endothelial assays, VEGFA biology, and apoptosis interpretation.
-
Gap19: Selective Connexin 43 Hemichannel Blocker
2026-09-21
Gap19 enables targeted Cx43 hemichannel inhibition while preserving gap junction channel function, making it useful for neuroglial, astrocyte, and inflammation-focused assays. This workflow-led guide connects ATP-release measurements, ischemia models, and Cx43/NF-κB signaling experiments with practical optimization and troubleshooting advice.
-
Sulfaphenazole Restores Perfusion in Ischemic Skin Injury
2026-09-21
Turner et al. show that sulfaphenazole reduces pressure- and thermal-injury severity in an ischemia–reperfusion model by rapidly restoring tissue perfusion and limiting hypoxia, inflammation, fibrosis, and impaired healing. The study supports CYP 2C inhibition as a vascular-protective strategy, while its mouse-model design also clarifies the evidence needed for translation to human wound care.
-
CTDNEP1–NEP1R1 Control of ER Lipid Fate
2026-09-20
This study shows that NEP1R1 stabilizes CTDNEP1 and is required for CTDNEP1-dependent restriction of ER expansion, but is dispensable for CTDNEP1 control of lipid droplet biogenesis. The work combines structure–function analysis, cellular perturbation, imaging, and biochemical assays to reveal that CTDNEP1 regulation is partitioned according to whether cells are producing membrane or storing neutral lipid.
-
Isoproterenol in Human Pacemaker Assembloids
2026-09-19
Human SAN–plexus assembloids create a powerful setting for separating intrinsic pacemaker maturation from acute adrenergic responsiveness. This article explains how Isoproterenol sulfate dihydrate can serve as a mechanistically focused perturbation tool for beta-adrenergic receptor signaling, cAMP/PKA pathway studies, and translational cardiovascular research.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-09-19
Oh et al. developed and validated a scalable human induced pluripotent stem cell-derived sensory neuron system for studying HSV-1 latency and reactivation. The model combines neuronal electrophysiology with virological and chromatin-based criteria, providing a human-relevant platform for investigating neuron-intrinsic mechanisms that are difficult to resolve in animal models.
-
Red Blood Cell Lysis Buffer Workflow Guide
2026-09-18
Build cleaner blood sample preparation workflows for flow cytometry, nucleic acid extraction, protein assays, and cell culture with selective erythrocyte removal. This guide combines practical starting conditions, assay-specific optimization, troubleshooting, and a careful translation of osteoblast research into blood-derived experimental designs.
-
MK-1775: Wee1 Kinase Inhibitor Workflows
2026-09-18
Build more informative checkpoint-abrogation experiments with MK-1775 by separating growth inhibition from true cell killing. This workflow combines mechanistic biomarkers, response timing, and combination designs to improve interpretation in p53-deficient tumor models.
-
Apigenin in Alzheimer’s Disease: A Network Medicine Study
2026-09-17
A 2025 study used network medicine to rank flavonoids by their proximity to Alzheimer’s disease-related targets and identified Apigenin as the leading candidate among four experimentally validated compounds. Cellular experiments linked its neuroprotective activity to preservation of mitochondrial function, suppression of apoptosis, AKT/NF-κB pathway modulation, and reduced microglia-associated inflammation.
-
Tianhuang Formula, RAGE/POMC, and Metabolism
2026-09-17
A 2026 pre-proof study identifies RAGE as a principal central nervous system target of berberine from Tianhuang Formula and links RAGE/POMC signaling with hypothalamic neuronal apoptosis, autophagy, and glucolipid control. Its integrated computational, analytical, cellular, and mouse-model design provides a mechanistic framework for metabolic neuroscience while leaving causal specificity and clinical translation unresolved.
-
Indole-3-pyruvic acid: Research Workflows
2026-09-16
Indole-3-pyruvic acid supports mechanistic studies spanning TAA1-regulated auxin biosynthesis and AhR-linked immune research. This workflow-focused guide covers assay design, fresh-solution handling, cross-domain interpretation, and troubleshooting for plant, fungal, and mammalian models.
-
Thioguanine Workflows for Cancer and EV71 Studies
2026-09-15
Thioguanine supports a practical bridge between cancer-cell pharmacology, epigenetic profiling, and EV71 virus inhibition. This workflow emphasizes solvent control, dose-window design, MIR9-pathway readouts, and troubleshooting so 6-thioguanine experiments produce interpretable rather than merely descriptive results.
-
Anlotinib Hydrochloride: From Assay to Tumor Biology
2026-09-15
Anlotinib hydrochloride connects receptor-level pharmacology with anti-angiogenic phenotypes and a clinically documented rare-tumor case. This article shows how to interpret endothelial assays, pathway data, pharmacokinetics, and translational evidence without confusing assay potency with clinical efficacy.
-
4-Hydroxytamoxifen Protocol and QC Guide
2026-09-14
This guide provides a practical DMSO-based workflow for 4-Hydroxytamoxifen, an estrogen receptor modulator used in controlled receptor, cancer, and cardiac-cell studies. It is not appropriate for protocols requiring direct water- or ethanol-soluble stocks, and the available dossier does not establish a universal dose, exposure schedule, or efficacy endpoint.
-
Metoprolol Tartrate in Translational Assays
2026-09-14
Metoprolol Tartrate is a selective β1-adrenergic blocking agent for separating cardiac receptor signaling from broader sympathetic effects. This guide translates that selectivity into practical cardiovascular and hematopoietic workflows, including comparator design, dosing logic, and troubleshooting.